chrX-120375382-C-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_001142447.3(ATP1B4):āc.573C>Gā(p.Asp191Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000415 in 1,205,442 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 19 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000054 ( 0 hom., 1 hem., cov: 21)
Exomes š: 0.000040 ( 0 hom. 18 hem. )
Consequence
ATP1B4
NM_001142447.3 missense
NM_001142447.3 missense
Scores
2
6
9
Clinical Significance
Conservation
PhyloP100: 2.52
Genes affected
ATP1B4 (HGNC:808): (ATPase Na+/K+ transporting family member beta 4) This gene has been found in all vertebrate genomes sequenced to date. However, this gene has undergone a change in function in placental mammals compared to other species. Specifically, in fish, avian, and amphibian species, this gene encodes plasma membrane-bound beta-subunits of Na,K-ATPase. In placental mammals, the encoded protein interacts with the nuclear transcriptional coregulator SKIP and may be involved in the regulation of TGF-beta signaling. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High Hemizygotes in GnomAdExome4 at 18 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ATP1B4 | NM_001142447.3 | c.573C>G | p.Asp191Glu | missense_variant | 5/8 | ENST00000218008.8 | |
ATP1B4 | NM_012069.5 | c.561C>G | p.Asp187Glu | missense_variant | 5/8 | ||
ATP1B4 | XM_017029381.2 | c.573C>G | p.Asp191Glu | missense_variant | 5/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ATP1B4 | ENST00000218008.8 | c.573C>G | p.Asp191Glu | missense_variant | 5/8 | 1 | NM_001142447.3 | P1 | |
ATP1B4 | ENST00000361319.3 | c.561C>G | p.Asp187Glu | missense_variant | 5/8 | 1 | |||
ATP1B4 | ENST00000539306.5 | c.444C>G | p.Asp148Glu | missense_variant | 4/7 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000541 AC: 6AN: 111000Hom.: 0 Cov.: 21 AF XY: 0.0000301 AC XY: 1AN XY: 33188
GnomAD3 genomes
AF:
AC:
6
AN:
111000
Hom.:
Cov.:
21
AF XY:
AC XY:
1
AN XY:
33188
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000451 AC: 8AN: 177538Hom.: 0 AF XY: 0.0000321 AC XY: 2AN XY: 62334
GnomAD3 exomes
AF:
AC:
8
AN:
177538
Hom.:
AF XY:
AC XY:
2
AN XY:
62334
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000402 AC: 44AN: 1094442Hom.: 0 Cov.: 29 AF XY: 0.0000500 AC XY: 18AN XY: 360054
GnomAD4 exome
AF:
AC:
44
AN:
1094442
Hom.:
Cov.:
29
AF XY:
AC XY:
18
AN XY:
360054
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000541 AC: 6AN: 111000Hom.: 0 Cov.: 21 AF XY: 0.0000301 AC XY: 1AN XY: 33188
GnomAD4 genome
AF:
AC:
6
AN:
111000
Hom.:
Cov.:
21
AF XY:
AC XY:
1
AN XY:
33188
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
4
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 13, 2023 | The c.573C>G (p.D191E) alteration is located in exon 5 (coding exon 5) of the ATP1B4 gene. This alteration results from a C to G substitution at nucleotide position 573, causing the aspartic acid (D) at amino acid position 191 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;.
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T;T;T
M_CAP
Benign
D
MetaRNN
Uncertain
D;D;D
MetaSVM
Benign
T
MutationAssessor
Benign
.;L;.
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;D
REVEL
Benign
Sift
Uncertain
D;D;T
Sift4G
Uncertain
D;D;D
Polyphen
D;D;D
Vest4
MutPred
0.50
.;Gain of disorder (P = 0.1101);.;
MVP
MPC
0.65
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at